Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transcriptional heterogeneity predicts and enables clonal selection in ageing haematopoiesis.

Research square·2026
Same author

Ploidy shapes gemcitabine response through altered potency and delayed cell death.

bioRxiv : the preprint server for biology·2026
Same author

The cost of fame for popular species: strong risk of biases in comparative oncology of captive species.

Proceedings. Biological sciences·2026
Same author

Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLC.

bioRxiv : the preprint server for biology·2026
Same author

When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.

NPJ precision oncology·2026
Same author

Age identifies cancer drivers hidden within the genome.

Nature genetics·2026
Same journal

Built environment is a key driver of cardiometabolic health in two Indigenous groups undergoing rapid lifestyle change.

Evolution, medicine, and public health·2026
Same journal

Adaptive therapy and its challenges.

Evolution, medicine, and public health·2026
Same journal

Competitive suppression and release in artemisinin-resistant <i>Plasmodium falciparum</i> field isolates.

Evolution, medicine, and public health·2026
Same journal

An evolutionary medicine perspective on the design of non-hormonal contraceptives for women.

Evolution, medicine, and public health·2026
Same journal

Daughters-in-law and mothers-in-law in lowland rural Nepal: The balance of power and health outcomes.

Evolution, medicine, and public health·2026
Same journal

Cancer, collapse, and the politics of somatic evolution.

Evolution, medicine, and public health·2026
查看所有相关文章

相关实验视频

Updated: Jun 11, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.7K

对瘤进展的新视角:通过功能选择的进化.

Frédéric Thomas1, James DeGregori2, Andriy Marusyk3

  • 1CREEC/CANECEV, MIVEGEC (CREES) Department, University of Montpellier, CNRS, IRD, Montpellier, France.

Evolution, medicine, and public health
|October 4, 2024
PubMed
概括
此摘要是机器生成的。

瘤发生涉及达尔文进化,但癌症的进展也需要特定的群体表型组成 (GPC). 这个GPC依赖于.

关键词:
进化 演化 演化 演化 演化 演化 演化 演化功能 功能 功能 功能 功能群体的表型组成 群体的表型组成这是一个前景,一个视角,一个视角.这是一个渐进的过程.选择的选择选择的选择.这些都是瘤,瘤.

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

9.5K

相关实验视频

Last Updated: Jun 11, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

9.5K

科学领域:

  • 进化生物学是进化的生物学.
  • 癌症研究 癌症研究
  • 理论生物学的理论生物学.

背景情况:

  • 瘤发生通常由达尔文进化论和自然选择对细胞的作用来解释.
  • 进展的瘤需要特定的群体表型组成 (GPC) 才能生存和生长.
  • 控制瘤GPCs的选择过程不同于经典的达尔文进化论.

研究的目的:

  • 挑战达尔文的过程单独完全解释瘤发生和癌症进展的观念.
  • 突出"功能选择"在瘤进化中的作用.
  • 为了解癌症提出一个更全面的进化框架.

主要方法:

  • 对癌症应用的进化理论的概念分析.
  • 将瘤进化与其他系统中的"功能选择"进行比较.
  • 基因多样性,GPC和瘤水平选择的论证综合.

主要成果:

  • 达尔文的过程产生了新型GPC所需的多样性.
  • 瘤GPC受到功能选择的影响,而不仅仅是不同的生殖成功.
  • 癌症的进展是一个复杂的进化场景,涉及多个层次的选择.

结论:

  • 达尔文进化论不足以解释瘤发生和癌症进展的所有方面.
  • 在瘤水平上选择功能对于癌症的进展至关重要.
  • 要充分理解癌症,需要一个细微的进化观点.